A detailed history of Lazard Asset Management LLC transactions in Poseida Therapeutics, Inc. stock. As of the latest transaction made, Lazard Asset Management LLC holds 797 shares of PSTX stock, worth $7,571. This represents 0.0% of its overall portfolio holdings.

Number of Shares
797
Previous 128 522.66%
Holding current value
$7,571
Previous $0 Infinity%
% of portfolio
0.0%
Previous 0.0%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$2.37 - $9.6 $1,585 - $6,422
669 Added 522.66%
797 $7,000
Q3 2024

Nov 14, 2024

SELL
$2.7 - $4.04 $548 - $820
-203 Reduced 61.33%
128 $0
Q2 2024

Aug 14, 2024

SELL
$2.0 - $3.46 $56,696 - $98,084
-28,348 Reduced 98.85%
331 $0
Q1 2024

May 14, 2024

BUY
$2.76 - $4.13 $58,340 - $87,299
21,138 Added 280.31%
28,679 $91,000
Q4 2023

Feb 14, 2024

SELL
$1.83 - $3.51 $44,877 - $86,075
-24,523 Reduced 76.48%
7,541 $25,000
Q3 2023

Nov 14, 2023

BUY
$1.62 - $2.79 $22,624 - $38,965
13,966 Added 77.17%
32,064 $76,000
Q2 2023

Aug 14, 2023

BUY
$1.66 - $3.4 $10,069 - $20,624
6,066 Added 50.42%
18,098 $31,000
Q1 2023

May 15, 2023

SELL
$3.08 - $8.73 $15,128 - $42,881
-4,912 Reduced 28.99%
12,032 $36,000
Q4 2022

Feb 14, 2023

BUY
$3.33 - $6.38 $56,423 - $108,102
16,944 New
16,944 $89,000

Others Institutions Holding PSTX

About Poseida Therapeutics, Inc.


  • Ticker PSTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 85,775,600
  • Market Cap $815M
  • Description
  • Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for patients with high unmet medical needs. The company develops P-PSMA-101, an autologous chimeric antigen receptor T cell (CAR-T) product candidate that is in Phase I trial for the treatment of patients with metastatic castrate resistant ...
More about PSTX
Track This Portfolio

Track Lazard Asset Management LLC Portfolio

Follow Lazard Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lazard Asset Management LLC with notifications on news.